Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending October 25, 2020 Switching to riociguat effective for some patients with PAH not at treatment goal, Certain statins linked to lower mortality risk in patients admitted for sepsis, Socioeconomic factors affect survival of multiple myeloma patients, Cardiogenic shock rate soars in COVID-positive ACS, Novel study explores link between primary immunodeficiencies, rheumatic diseases, More must reads Must reads for theWeek ending October 18, 2020 Budesonide orodispersible tablets maintained remissions in EoE, Social factors predicted peripartum depressive symptoms in Black women with HIV, Substance in tears could be used for diabetes monitoring, Diarrhea prevalent among COVID-19 patients with IBD, HIT-6 may help track meaningful change in chronic migraine, More must readsMust reads for theWeek ending October 11, 2020 Remdesivir effective, well-tolerated in final trial report, More data on impact of corticosteroids on COVID-19 mortality in patients with COPD, Alcohol problems linked to legal performance-enhancement products, New lupus classification criteria perform well in children, young adults, Older adults with multiple myeloma face heavy burden of care, More must readsMust reads for theWeek ending October 4, 2020 Screening algorithm safely selects patients for OSA treatment before bariatric surgery, Genetics and epigenetics could predict response to RA therapies, Pandemic drives demand for self-managed abortions, Higher glycemic time in range may benefit T2D patients, Exercise cuts diabetes death risk by a third in two studies, More must readsMust reads for theWeek ending September 27, 2020 Review finds evidence for beta-blockers for some rosacea symptoms, DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use, No prior use of insulin predicts postsurgical diabetes remission, Nationwide study questions routine long-term beta-blocker post MI, Vascular dementia risk particularly high in type 2 diabetes, More must readsPages1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 last ยป
